Classification CIB

Sections
C - Chimiemétallurgie
C07K - Peptides
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères

Détention brevets de la classe C07K 14/47

1027	1091	1231	1318	1347	1439	1413	1305	1246	445
2016	2017	2018	2019	2020	2021	2022	2023	2024	2025

Proprétaire	Total	Cette classe
Immatics Biotechnologies GmbH	1151	706
The Regents of the University of California	19780	305
Regeneron Pharmaceuticals, Inc.	4201	153
The Trustees of the University of Pennsylvania	4289	140
President and Fellows of Harvard College	5932	135
Inserm (institut National de La Sante et de La Recherche Medicale)	3357	131
Dana-Farber Cancer Institute, Inc.	2545	123
The Board of Trustees of the Leland Stanford Junior University	6322	120
Centre National de La Recherche Scientifique	10266	103
The United States of America, as represented by the Secretary, Department of Health and Human Services	2832	90
The General Hospital Corporation	4695	87
University of Florida Research Foundation, Inc.	3970	83
Massachusetts Institute of Technology	9975	82
The Johns Hopkins University	5626	82
Research Institute at Nationwide Children's Hospital	551	78
Sangamo Therapeutics, Inc.	415	78
Institut National de La Sante et de La Recherche Medicale (inserm)	2732	76
Board of Regents, The University of Texas System	5736	69
Memorial Sloan-Kettering Cancer Center	1901	66
Novartis AG	10975	63
Autres propriétaires		13198